Pulmonary complications associated with the treatment of patients with congenital cardiac disease: consensus definitions from the Multi-Societal Database Committee for Pediatric and Congenital Heart Disease
David S. Cooper(Cincinnati Children's Hospital Medical Center), Peter B. Manning(St. Louis Children's Hospital), Jeffrey P. Jacobs(University of Florida), Paul J. Chai(Emory University), Otto N. Krogmann, James Jaggers(Children's Hospital Colorado), Robert H. Beekman(Cincinnati Children's Hospital Medical Center), Paul Barach(Massachusetts General Hospital)
Cited by 39
Related Papers
Indications for Cardiac Catheterization and Intervention in Pediatric Cardiac Disease
|Circulation|2011|848
2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials
|Circulation|2014|702
2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials
|Journal of the American College of Cardiology|2014|596
NGAL is an early predictive biomarker of contrast-induced nephropathy in children
|Pediatric Nephrology|2007|459